GlassScriptPhysician profile
Darby Day
NPI 1174275457
$4,788.08
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,747 · 2023: $2,124 · 2024: $918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,041.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $760.73 | 2022-2024 | Austedo Xr, Austedo, Uzedy |
| Janssen Pharmaceuticals, INC | $738.39 | 2022-2024 | Invega Sustenna, Invega Trinza |
| Otsuka America Pharmaceutical, INC. | $570.69 | 2022-2024 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $501.22 | 2022-2024 | Caplyta |
| Abbvie INC. | $424.18 | 2022-2024 | |
| Alkermes, INC. | $368.56 | 2022-2024 | Aristada, Lybalvi |
| Lundbeck LLC | $347.03 | 2022-2024 | Rexulti |
| Indivior INC. | $323.43 | 2022-2024 | Perseris |
| Vanda Pharmaceuticals INC. | $308.49 | 2022-2023 | Fanapt, Hetlioz |
| Neurocrine Biosciences, INC. | $260.86 | 2022-2024 | Ingrezza |
| Almatica Pharma LLC | $46.02 | 2024 | Loreev Xr |
| Supernus Pharmaceuticals, INC. | $34.42 | 2023 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $32.92 | 2022 | |
| Tempus Ai, INC | $24.41 | 2024 | |
| Avanir Pharmaceuticals, INC. | $19.17 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $15.41 | 2023 | Auvelity |
| Noven Therapeutics, LLC | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darby Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.